trending Market Intelligence /marketintelligence/en/news-insights/trending/K5aEguKE7PZgjpZPEwS7uA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Pfizer's Viagra Connect granted over-the-counter status in UK

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Pfizer's Viagra Connect granted over-the-counter status in UK

The U.K.'s Medicines and Healthcare products Regulatory Agency has allowed Pfizer Inc.'s Viagra Connect to be sold without a prescription in pharmacies.

The regulator granted the reclassification Viagra Connect as a non-prescription pharmacy medicine to treat erectile dysfunction in men aged 18 and above.

Pfizer intends to launch the non-prescription version of Viagra in the U.K. in the spring of 2018.

Viagra Connect will be distributed only in pharmacies and will be given depending on the pharmacists' assessment of suitability for the patients with erectile dysfunction symptoms.

The Viagra tablet will still be available as a prescription medicine.